AltaScience has carried out clinical trials with AltaSeal® in Ireland and The Netherlands. Patients recruited to the trials have had the AltaSeal® implants placed as an outpatient procedure without the need for general anaesthetic. The clinical trials have covered it's use as a sterilisation device. In addition the device has been used to occlude fallopian tubes in patients with hydrosalpinges who have had previous failed IVF therapy with excellent clinical results.
The development of AltaSeal® was recently reported in a peer reviewed journal, the article is titled Development and Initial Clinical Experience with AltaSeal®: A Novel Hysterscopically Placed Permanent Contraception System. (See below). The paper concludes that’s to date AltaSeal® can efficiently occlude fallopian tubes for both prevention of pregnancy and possibly return the rate of successful IVF treatments in patients with hydrosalpinges to levels seen in patients without hydrosalpinges.
THIS DEVICE IS NOT YET FOR SALE IN THE UNITED STATES
– IT IS AN INVESTIGATIONAL DEVICE LIMITED BY FEDERAL (OR UNITED STATES) LAW TO INVESTIGATIONAL USE.